These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 3066365)

  • 1. Penetrability of ofloxacin into cultured epithelial cells and macrophages.
    Une T; Osada Y
    Arzneimittelforschung; 1988 Sep; 38(9):1265-7. PubMed ID: 3066365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of oral quinolones (norfloxacin, ciprofloxacin, ofloxacin).
    Alestig K
    Scand J Infect Dis Suppl; 1990; 68():19-22. PubMed ID: 2218417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative activity of quinolones (ciprofloxacin, levofloxacin, moxifloxacin and garenoxacin) against extracellular and intracellular infection by Listeria monocytogenes and Staphylococcus aureus in J774 macrophages.
    Seral C; Barcia-Macay M; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
    J Antimicrob Chemother; 2005 Apr; 55(4):511-7. PubMed ID: 15731197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative tear concentrations of topically applied ciprofloxacin, ofloxacin, and norfloxacin in human eyes.
    Akkan AG; Mutlu I; Ozyazgan S; Gök A; Yigit U; Ozüner Z; Senses V; Pekel H
    Int J Clin Pharmacol Ther; 1997 May; 35(5):214-7. PubMed ID: 9174877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norfloxacin, ciprofloxacin, and ofloxacin: current clinical roles.
    Hooper DC; Wolfson JS
    Curr Clin Top Infect Dis; 1989; 10():194-240. PubMed ID: 2679694
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative in vitro activity of 10 new 4-quinolones against enteropathogenic bacteria].
    Habiyaremye I; Verbist L; Vandepitte J
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):800-4. PubMed ID: 3116489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule.
    Wise R; Griggs D; Andrews JM
    Rev Infect Dis; 1988; 10 Suppl 1():S83-9. PubMed ID: 3162327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intracellular penetration of 5 quinolones into non-phagocytic cells].
    García I; Pascual A; Conejo MC; Perea EJ
    Enferm Infecc Microbiol Clin; 1996 Mar; 14(3):167-70. PubMed ID: 8695686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative penetration of lomefloxacin and other quinolones into human phagocytes.
    Perea EJ; García I; Pascual A
    Am J Med; 1992 Apr; 92(4A):48S-51S. PubMed ID: 1316071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Modulation by quinolones of the in vitro proliferative response of splenic cells of the mouse and IL 1 production].
    Guenounou M; Ronco E; Kodari E; Vacheron F; Momrikof V
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):785-9. PubMed ID: 3309816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of ferrous sulphate on the absorption of norfloxacin, ciprofloxacin and ofloxacin.
    Lehto P; Kivistö KT; Neuvonen PJ
    Br J Clin Pharmacol; 1994 Jan; 37(1):82-5. PubMed ID: 8148225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro fluoroquinolone resistance in ocular bacterial isolates].
    Sun XG; Wang ZQ; Li R; Chen L; Jin XY; Luo SY
    Zhonghua Yan Ke Za Zhi; 2003 Mar; 39(3):163-6. PubMed ID: 12880574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative in vitro study of the activity of 5 quinolones against Acinetobacter calcoaceticus].
    Joly-Guillou ML; Bergogne-Berezin E
    Pathol Biol (Paris); 1985 May; 33(5):416-20. PubMed ID: 3162142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinolone therapy in intensive care unit settings.
    Beam TR
    New Horiz; 1993 May; 1(2):187-93. PubMed ID: 7922402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of topically applied ciprofloxacin in rabbit tears.
    Green LC; Callegan MC; Engel LS; Shimomura Y; Jasheway DW; O'Callaghan RJ; Hill JM
    Jpn J Ophthalmol; 1996; 40(1):123-6. PubMed ID: 8739510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of ciprofloxacin and ofloxacin using human corneal susceptibility levels.
    Kowalski RP; Karenchak LM; Gordon YJ
    Cornea; 1998 May; 17(3):282-7. PubMed ID: 9603384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of in vitro activities of the fluoroquinolones to their in vivo efficacies.
    Fernandes PB; Swanson RN
    Drugs Exp Clin Res; 1988; 14(6):375-8. PubMed ID: 3145851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Salmonella typhi and Salmonella typhimurium invasion, intracellular growth and localization in cultured human epithelial cells.
    Mills SD; Finlay BB
    Microb Pathog; 1994 Dec; 17(6):409-23. PubMed ID: 7752882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative antimicrobial activity of lomefloxacin, norfloxacin, ofloxacin, ciprofloxacin and enoxacin against > 500 bacterial isolates.
    Ismaeel NA; Tayeb OS
    Microbios; 1993; 74(300):147-54. PubMed ID: 8396196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminoglycosides affect intracellular Salmonella enterica serovars typhimurium and virchow.
    Menashe O; Kaganskaya E; Baasov T; Yaron S
    Antimicrob Agents Chemother; 2008 Mar; 52(3):920-6. PubMed ID: 18172002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.